Loading...
Invion Limited
IVX.AX•ASX
Healthcare
Drug Manufacturers - Specialty & Generic
A$0.10
A$0.003(3.13%)
Invion Limited (IVX.AX) Financial Performance & Income Statement Overview
Review Invion Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-10.00%
↓ 10.00%
Operating Income Growth
-358.13%
↓ 358.13%
Net Income Growth
-248.51%
↓ 248.51%
Operating Cash Flow Growth
-32.47%
↓ 32.47%
Operating Margin
-521.20%
↓ 521.20%
Gross Margin
-13.82%
↓ 13.82%
Net Profit Margin
-462.94%
↓ 462.94%
ROE
-49.23%
↓ 49.23%
ROIC
-58.19%
↓ 58.19%
Invion Limited (IVX.AX) Income Statement & Financial Overview
Review Invion Limited's (IVX.AX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $736447.00 | $783526.00 | $1.94M | $4.08M |
| Short Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Cash & Short Term Investments | $736447.00 | $783526.00 | $1.94M | $4.08M |
| Net Receivables | $0.00 | $1.21M | $2.45M | $1.62M |
| Inventory | $0.00 | $0.00 | $0.00 | $1.00 |
| Other Current Assets | $157505.00 | $87244.00 | $175899.00 | $59874.00 |
| Total Current Assets | $893952.00 | $2.08M | $4.57M | $5.76M |
| Property Plant & Equipment (Net) | $29917.00 | $39474.00 | $48927.00 | $58483.00 |
| Goodwill | $0.00 | $0.00 | $0.00 | $0.00 |
| Intangible Assets | $12.93M | $13.33M | $13.73M | $13.23M |
| Goodwill & Intangible Assets | $12.93M | $13.33M | $13.73M | $13.23M |
| Long Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Tax Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Assets | $0.00 | $0.00 | $0.00 | -$13.29M |
| Total Non-Current Assets | $12.96M | $13.37M | $13.78M | $13.29M |
| Total Assets | $13.85M | $15.45M | $18.35M | $19.05M |
| Account Payables | $623024.00 | $720948.00 | $422063.00 | $399771.00 |
| Short Term Debt | $0.00 | $0.00 | $0.00 | $0.00 |
| Tax Payables | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Liabilities | $99038.00 | $292866.00 | $75269.00 | $250854.00 |
| Total Current Liabilities | $722062.00 | $1.01M | $497332.00 | $650625.00 |
| Long Term Debt | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Revenue Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Tax Liabilities Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Liabilities | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Non-Current Liabilities | $0.00 | $0.00 | $0.00 | $0.00 |
| Capital Lease Obligations | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $722062.00 | $1.01M | $497332.00 | $650625.00 |
| Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock | $149.17M | $148.35M | $146.88M | $146.88M |
| Retained Earnings | -$137.61M | -$136.08M | -$131.17M | -$130.48M |
| Accumulated Other Comprehensive Income/Loss | $1.56M | $2.16M | $2.14M | $1.99M |
| Total Stockholders Equity | $13.13M | $14.44M | $17.86M | $18.40M |
| Total Equity | $13.13M | $14.44M | $17.86M | $18.40M |
| Total Liabilities & Stockholders Equity | $13.85M | $15.45M | $18.35M | $19.05M |
| Total Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Debt | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Debt | -$736447.00 | -$783526.00 | -$1.94M | -$4.08M |
Invion Limited (IVX.AX) Balance Sheet Analysis
Invion Limited (IVX.AX) manages its money wisely, with plenty of -32.47% and -248.51% to cover its bills. The company’s long-term debts are N/A, balanced by steady -462.94%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a cautious position, giving it room to invest, expand, or adapt. For investors, this paints a risky picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan